“…It seems likely that diabetes-induced impairment of endothelium-dependent vasorelaxation also contributes to this early vasoconstrictor phase possibly through a mechanism involving downregulation of retinal endothelial TRPV4 channels (De Vriese et al, 2000;Fitzgerald et al, 2005;Ito et al, 2006;Kawagishi et al, 1999;Monaghan et al, 2015;Yu et al, 2003). As diabetic retinopathy develops, the progressive loss of pressure and metabolic autoregulatory mechanisms (Grunwald et al, 1984;Patel et al, 1994;Rassam et al, 1995;Sinclair et al, 1982;Trick et al, 2006) disturbances in retinal vasomotion (Bek, 2013;Bek et al, 2013b) and the release of dilatory factors from the hypoxic retina such as lactate, adenosine and VEGF (Clermont et al, 1997;Gidday and Park, 1993;Hein et al, 2006;Yamanishi et al, 2006) most likely underlies the switch to retinal hyperperfusion (Curtis and Gardiner, 2012). Further research elucidating the basic mechanisms controlling blood flow autoregulation in the retina will be essential if we are fully understand why this process becomes disrupted during diabetes.…”